C. Wan

发表

Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

A. Wolf, J. Fowler, N. Gutterson, 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose

M. Reivich, D. Kuhl, A. Wolf, 1978 .

A FLUORINATED GLUCOSE ANALOG, 2‐FLUORO-2‐DEOXY-D‐GLUCOSE (F‐18): NONTOXIC TRACER FOR RAPID TUMOR DETECTION

J S Fowler, R R MacGregor, H. Atkins, 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A synthesis of 2-deoxy-D-[1-11C]glucose for regional metabolic studies: concise communication.

A. Wolf, J. Fowler, R. Macgregor, 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Fluorination with F/sub 2/. A convenient synthesis of 2-deoxy-2-fluoro-D-glucose

A. Wolf, J. Fowler, T. Ido, 1977 .

Reactions of oxetane with imine salts derived from cyclohexanone

C. Wan, P. F. Hudrlik, 1975 .

Pyrolytic rearrangements of α,β-epoxysilanes to silyl enol ethers

C. Wan, P. F. Hudrlik, G. P. Withers, 1976 .

.alpha.-Methyleneoxetane. Retro-Diels-Alder reaction

C. Wan, P. F. Hudrlik, A. Hudrlik, 1975 .

Preparation of a Trans a,-Epoxysilane by Selective Pyrolysis

C. Wan, P. F. Hudrlik, 1979 .

Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals.

J S Fowler, R R MacGregor, D E Kuhl, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tissue distributions of radiopharmaceuticals labeled with positron emitters and problems in relating them to human studies

A. Wolf, J. Fowler, D. Christman, 1983 .

11C-labeled octanal and benzaldehyde†

A. Wolf, C. Wan, A. Lipman, 1979 .

Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. 2.

D. Davey, C. Wan, W. C. Lumma, 1987, Journal of medicinal chemistry.

METABOLIC TRAPPING AS A PRINCIPLE OF RADIO-PHARMACEUTICAL DESIGN: SOME FACTORS RESPONSIBLE FOR THE BIODISTRIBUTION OF 18F-2-DEOXY-2-FLUORO-D-GLUCOSE

A. Wolf, J. Fowler, N. Gutterson, 1979 .